Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group has announced its intention to acquire the remaining 7% stake in a pharmaceutical unit based in Chengdu, China.

The deal is valued at ¥72.9 million ($10.8 million) and will increase the acquirer company’s stake in the target company to 100%.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

"Chinese company Cachet Pharmaceutical has announced its intention for a ¥18 million ($2.67 million) acquisition of a 51% stake in another Chinese pharmaceutical company based in Xi'an."

Chinese company Cachet Pharmaceutical has announced its intention for a ¥18 million ($2.67 million) acquisition of a 51% stake in another Chinese pharmaceutical company based in Xi'an.

Antegrin Therapeutics has announced that it has completed a merger with Cascadia Therapeutics to form a new biotechnology company named Indalo Therapeutics, which will be run by consolidated management teams from the two companies.

The new entity will focus on developing therapies aimed at treating fibrotic diseases, which represent a huge unmet medical need.

Both companies involved in the merger are based in the US.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now